• |
Afpedia > Products >Chemicals >Biochemical Industry >Finished Medicine> Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried

Supplier Details

  • Changchun Zhuoyi Biological Co., Ltd

  • This supplier is an uncertified member of Afrindex. To ensure your interest, Afrindex will first verify this supplier information before publishing his contacts.
  • Location: ******
  • Tel: ******
  • Mobile: ******
  • Email: ******

Service For Buyers

Service For Sellers

Africa Buyer List

Hot Products

Sponsor Advertsing

Apply For Ranking

Apply now and get access to more privileges of being hot recommended with best ranking.

Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried

  • FOB Price : US $4-6
  • MOQ: 50000 vials
  • Port : depends
  • Payment Terms : T/T,L/C
  • Production Capacity: 1000000 vilas

Inquiry

Add to My Basket You can manage your basket in member center

  • Basic Info
  • Company Profile
  • Packaging Details:under discussion
  • Origin:changchun,jilin
  • Model Number:pending
  • Brand Name:Bioshoot

Product Description

  • The strain of rabies virus CTN-1V is produced as the virus species.  The homology of CTN strain and nucleotide of various strains in China is 82% to 93%, homology between which is greater than that of other vaccine strains, and more suitable for domestic use in China.

    Adopt the world's leading U.S. NBS bioreactor

    Adopt the large-scale cultivation process of world’s leading U.S. NBS40L bioreactor , together with the easy-to-attach, high-yield polyester chip carrier (Fibra-Cel Disk), to achieve stability control on the entire cultivation process, and greatly reduced exogenous pollution risks.

    Adopt No antibiotics-added during whole production process technology. Without residual antibiotics and side-effect problem, vaccination response incidence is greatly decreased.

    Quality indices are better than national standards

Photo Show

  • Located in Economic Development Zone, Shuangyang District, Changchun. Changchun Zhuoyi Biological Co., Ltd. is a key vaccine manufacturing company in Jilin province invested by Zhejiang Serkoning Biotechnology Co., Ltd.

     

    Founded on Jan. 27th, 2005, Zhuoyi Bio is with a registered capital of 95.08 million yuan and a total area of 41,600 square meters. It has a leading domestic vaccine research and development and production capabilities.

       

    Changchun Zhuoyi Biological Co., Ltd. devotes to the R&D, manufacture and sale of new-type vaccine. Biological product currently approved in the company is Freeze-dried Rabies Vaccine (Vero Cell) for Human Use. Zhuoyi Bio successfully passed the two-in-one inspection and obtained registration approval and GMP certificate at the end of 2016. Officially put into production in Jan., 2017. The company's existing workshop covers an area of approximately 5,700 square meters, with a total investment of 300 million yuan, and a maximum annual output of 1 million copies. The second-phase workshop was completed

    at the end of 2017, with a production capacity of 4 million people.

     

    Zhuoyi Bio has nearly 2,000 square meters of pilot research workshops, including bioreactors, ultrafiltration systems, AKTA purification workstations, fluorescence microscopes and other advanced equipment for virus cultivation, purification system improvement and the identification of recombinant proteins. Our company maintains close scientific research cooperation relationships with a number of research institutes at home and abroad. Currently, our cooperating projects include human papillomavirus 16/18/58/52 tetravalent vaccines, new compound adjuvant rabies vaccines, rotavirus vaccines and

    other R&D projects.
  • More >

Basic Information

  • Chemicals-Biochemical Industry-Finished Medicine
  • 2005-01-17
  • manufacturing enterprise
  • The strain of rabies virus CTN-1V is produced as the virus species. The homology of CTN strain and nucleotide of various strains in China is 82% to 93%, homology between which is greater than that of other vaccine strains, and more suitable for domestic use in China. Adopt the world's leading U.S. NBS bioreactor Adopt the large-scale cultivation process of world’s leading U.S. NBS40L bioreactor , together with the easy-to-attach, high-yield polyester chip carrier (Fibra-Cel Disk), to achieve stability control on the entire cultivation process, and greatly reduced exogenous pollution risks. Adopt No antibiotics-added during whole production process technology. Without residual antibiotics and side-effect problem, vaccination response incidence is greatly decreased. Quality indices are better than national standards 0.5ml/dose，more convenient and safer Less side effect. Higher safety. Single dose package for convenient use.
  • Asia
  • 25%-60%
  •  YES
Subject:
To:
Message:
Enter between 20 to 4,000 characters
Send

About Us | VIP Service | Careers | Contact Us | Legal Notices | Site Map Tel:+86-028-68731189    E-mail:server@afcan.cn

Copyright 2017 Afrindex.com All Rights Reserved